New Health Studies Highlight Risks—and Hope—for Americans

Three recent medical studies are shedding light on some of the most pressing health challenges facing Americans today—from growing risks of liver damage to the rising number of pharmacy closures, as well as new hope for cancer treatment.

Liver damage risks increase with common health conditions

A study published in the Journal of Clinical Gastroenterology and Hepatology found that alcohol use nearly doubles the risk of severe liver damage in people with certain underlying conditions, including large waistlines, diabetes, or high blood pressure.

This finding is particularly concerning given how common those conditions are. According to CNN, nearly half of all Americans have high blood pressure, and more than a third have pre-diabetes.

Researchers say that while alcohol on its own poses a risk to liver health, it becomes much more harmful when combined with these other health factors. Medical experts recommend limiting alcohol use and focusing on healthier habits to reduce the long-term risk of liver damage.

Pharmacy closures create barriers for older adults

Another major concern is the growing number of pharmacy closures across the country. A study published in Health Affairs found that nearly 30 percent of U.S. pharmacies shut their doors between 2010 and 2021. These closures have created what researchers call “pharmacy deserts,” where access to medication and basic health services is limited or unavailable.

The problem is especially serious for older adults. According to reporting from the New York Times, the vast majority of seniors rely on at least one prescription medication each year. Pharmacies also play a major role in providing vaccinations—dispensing roughly 80 percent of shingles vaccines and as much as 70 percent of flu shots nationwide.

Health experts warn that limited pharmacy access could delay care for seniors and increase their risk of health complications. The impact is greatest in rural and low-income areas, where pharmacy closures are more common and alternatives are harder to find.

Personalized kidney cancer vaccine shows promise

While some studies reveal growing health risks, there is also good news from the field of cancer research. A small clinical trial has shown encouraging results for a personalized kidney cancer vaccine developed by researchers at Harvard Medical School’s Dana-Farber Cancer Institute.

In the trial, nine patients with advanced kidney cancer received individualized vaccines made from genetic material taken directly from their own tumors. The goal of the vaccine was to train each person’s immune system to recognize and destroy cancer cells.

All nine participants in the trial showed measurable immune responses. According to Harvard researchers, these early results suggest that personalized cancer vaccines could become a viable treatment option in the future. Scientists believe this is a strong step forward in the development of precision medicine, where treatments are designed specifically for each patient.

Looking ahead

Together, these studies highlight the changing landscape of health care in the United States. They reflect both the challenges many Americans face—like chronic disease risks and limited access to care—and the hope offered by new scientific advances.

As health issues continue to evolve, researchers emphasize the importance of prevention, early detection, and access to quality care. Staying informed and making healthy choices remain key tools for improving long-term health and well-being.